↓ Skip to main content

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia

Overview of attention for article published in Cochrane database of systematic reviews, January 2014
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
policy
1 policy source
twitter
86 tweeters
facebook
3 Facebook pages
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
300 Dimensions

Readers on

mendeley
488 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia
Published in
Cochrane database of systematic reviews, January 2014
DOI 10.1002/14651858.cd007115.pub3
Pubmed ID
Authors

Michael PT Lunn, Richard AC Hughes, Philip J Wiffen

Abstract

Duloxetine is a balanced serotonin and noradrenaline reuptake inhibitor licensed for the treatment of major depressive disorders, urinary stress incontinence and the management of neuropathic pain associated with diabetic peripheral neuropathy. A number of trials have been conducted to investigate the use of duloxetine in neuropathic and nociceptive painful conditions. This is the first update of a review first published in 2010.

Twitter Demographics

The data shown below were collected from the profiles of 86 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 488 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
Canada 1 <1%
Switzerland 1 <1%
Brazil 1 <1%
Denmark 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 479 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 87 18%
Student > Bachelor 68 14%
Researcher 63 13%
Student > Postgraduate 47 10%
Student > Ph. D. Student 42 9%
Other 117 24%
Unknown 64 13%
Readers by discipline Count As %
Medicine and Dentistry 209 43%
Nursing and Health Professions 55 11%
Pharmacology, Toxicology and Pharmaceutical Science 28 6%
Psychology 25 5%
Neuroscience 17 3%
Other 67 14%
Unknown 87 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 84. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2021.
All research outputs
#302,792
of 17,501,053 outputs
Outputs from Cochrane database of systematic reviews
#646
of 11,704 outputs
Outputs of similar age
#4,172
of 274,056 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 157 outputs
Altmetric has tracked 17,501,053 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,704 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 274,056 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 157 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.